Abiopharma

agilon health - agilon health Reports Second Quarter 2025 Results

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 144 - Kiniksa Pharmaceuticals International, plc Filed: 2025-08-04 AccNo: 0001921094-25-000868 Size: 5 KB

agilon health - agilon health Announces Leadership Transition

agilon health Announces Leadership Transition

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

New Form 144 - Kiniksa Pharmaceuticals International, plc Filed: 2025-08-04 AccNo: 0001921094-25-000867 Size: 5 KB

Ardelyx Announces Changes to the Executive Leadership Team

New Form 8-K - GILEAD SCIENCES, INC. Filed: 2025-08-04 AccNo: 0000882095-25-000022 Size: 495 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073629 Size: 5 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004993 Size: 9 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004992 Size: 9 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004991 Size: 11 KB

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Best Bathroom Dehumidifier Options for Humidity Control in 2025